First Line Prevent Age Study
Prevent Age Resort "Pervaya Liniya"
100 participants
Feb 1, 2025
INTERVENTIONAL
Conditions
Summary
To prove the effectiveness of complex wellness programs in terms of maintaining active longevity, including motivational counseling, high-intensity training, intermittent fasting, hypoxic training, as well as practices for achieving healthy sleep and mental well-being. Clinical-instrumental, single-centre, prospective, open-label, non-randomized, sequential enrollment study with blinded endpoint analysis
Eligibility
Inclusion Criteria4
- Men and women over 18;
- No significant (affecting the functional state) "active" diseases: acute diseases and exacerbations of chronic diseases;
- Interest in active longevity and willingness to participate in research.
- Signed informed consent.
Exclusion Criteria13
- Age up to 18 years;
- Severe or moderate comorbidities;
- Rheumatological (systemic / autoimmune) diseases of any severity;
- Intestinal infections (within 3 months);
- SARS / pneumonia, other diseases accompanied by systemic inflammation during the last 2 months;
- Chronic inflammatory bowel disease;
- Major surgery within the last 3 months
- Intoxication (alcohol, drugs, other toxins);
- Oncological disease (except for basalioma) out of remission;
- Persons with mental illness;
- Diabetes;
- Syndrome of obstructive sleep apnea of moderate and severe severity;
- Low adherence to lifestyle interventions, including physical activity of less than 150 minutes of aerobic activity per week (at least two days per week) or 75 minutes of vigorous exercise (at least 3 days per week).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
1. Nutrition: intermittent fasting; 2. Physical activity: medium-intensity or high-intensity physical activity; 3. Hypoxic training (at least three per visit to the center); 4. correction of hygiene and sleep duration, relaxation techniques, cognitive behavioral therapy for insomnia. 5. Individual motivational counseling.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05361343